Technological innovations have resulted in more rational drug design, bringing hope of better treatments to patients who have been diagnosed with advanced cancer but who may have stopped benefitting from traditional treatments such as chemotherapy.
For Irish patients it is difficult however to gain access to the cutting edge of drug development and accessing new drugs is a serious issue for patients and doctors in this country.
To address this, the Mater hospital is partnering with The START Centre for Cancer Care, a US physician-owned clinical trials group and one of the global leaders in early...